The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
A Review of the Preclinical Pharmacology of Tiagabine: A Potent and Selective Anticonvulsant GABA Uptake Inhibitor
Abstract
Summary: We review the neurochemical and behavioral profile of the selective γ‐aminobutyric acid (GABA) up‐take inhibitor, (R)‐N‐(4,4‐di‐(3‐methylthien‐2‐yl)but‐3‐enyl) nipecotic acid hydrochloride [tiagabine (TGB), previously termed NNC 05‐0328, NO 05‐0328, and NO‐328], which is currently in phase III clinical trials for epilepsy. TGB is a potent, and specific GABA uptake inhibitor. TGB lacks significant affinity for other neurotransmitter receptor binding sites and/or uptake sites. In electrophysiological experiments in hippocampal slices in culture, TGB prolonged the inhibitory postsynaptic potentials (IPSP) and inhibitory postsynaptic currents (IPSC) in the CA1 and CA3 produced by the addition of exogenous GABA. In vivo microdialysis shows that TGB also in‐creases extracellular GABA overflow in a dose‐dependent manner. Together these biochemical data suggest that the in vitro and in vivo mechanism of action of TGB is to inhibit GABA uptake specifically, resulting in an increase in GABAergic mediated inhibition in the brain. TGB is a potent anticonvulsant agent against methyl‐6,7‐dimethyox‐4‐ethyl‐B‐carboline‐3‐carboxylate (DMCM)‐induced clonic convulsions (mice), subcutaneous pentylenetetrazol (PTZ)‐induced tonic convulsions (mice and rats), sound‐induced convulsions in DBA/2 mice and genetically epilepsy‐prone rats (GEPR), and electrically induced convulsions in kindled rats. TGB is partially efficacious against subcutaneous PTZ‐induced clonic convulsions, and photically induced myoclonus in Papio papio. TGB is weakly efficacious in the intravenous PTZ seizure threshold test and the maximal electroshock seizure (MES) test and produces only partial protection against bicuculline (BIC)‐induced convulsions in rats. The overall biochemical and anticonvulsant profile of TGB suggests potential utility in the treatment of chronic seizure disorders such as generalized clonic‐tonic epilepsy (GTCS), photomyoclonic seizures, myoclonic petit mal epilepsy, and complex partial epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: The third generation of progress
O'Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,013
Cloning and Expression of a Rat Brain GABA Transporter
Guastella, J., Nelson, N., Nelson, H., Czyzyk, L., Keynan, S., Miedel, M. C., Davidson, N., Lester, H. A., & Kanner, B. I. (1990) · Science · doi:10.1126/science.1975955 · Cited by 879
Löscher, W., & Schmidt, D. (1988) · Epilepsy Research · doi:10.1016/0920-1211(88)90054-x · Cited by 806
Bowery, N. G. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.000545 · Cited by 599
GABA in Nervous System Function
Marsden, C. D. (1977) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.40.3.308-c · Cited by 550
Two different responses of hippocampal pyramidal cells to application of gamma‐amino butyric acid.
Andersen, P., Dingledine, R., Gjerstad, L., Langmoen, I. A., & Laursen, A. M. (1980) · The Journal of Physiology · doi:10.1113/jphysiol.1980.sp013363 · Cited by 482
Liu, Q. R., López-Corcuera, B., Mandiyan, S., Nelson, H., & Nelson, N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53968-5 · Cited by 418
Di Chiara, G., Porceddu, M. L., Morelli, M., Mulas, M. L., & Gessa, G. L. (1979) · Brain Research · doi:10.1016/0006-8993(79)90983-1 · Cited by 400
Grace, A. A., & Bunney, B. S. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90283-8 · Cited by 391
Inhibitory, GABAergic Nerve Terminals Decrease at Sites of Focal Epilepsy
Ribak, C. E., Harris, A. B., Vaughn, J. E., & Roberts, E. (1979) · Science · doi:10.1126/science.109922 · Cited by 344
Cited by
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans
Werhahn, K. J., Kunesch, E., Noachtar, S., Benecke, R., & Classen, J. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0591t.x · Cited by 887
GABAergic Mechanisms in Epilepsy
Treiman, D. M. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.042suppl.3008.x · Cited by 836
A summary of mechanistic hypotheses of gabapentin pharmacology
Taylor, C. P., Gee, N. S., Su, T.-Z., Kocsis, J. D., Welty, D. F., Brown, J. P., Dooley, D. J., Boden, P., & Singh, L. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(97)00084-3 · Cited by 774
Mehta, A. K., & Ticku, M. K. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00052-6 · Cited by 625
Metadata
- Authors
- Suzdak, P. D., & Jansen, J. A.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1995-06
- Volume
- 36
- Issue
- 6
- Pages
- 612-626
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2021334241
- Cited by
- 278
- References
- 48
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review of the Preclinical Pharmacology of Tiagabine: A Potent and Selective Anticonvulsant GABA Uptake Inhibitor. https://app.cochat.ai/papers/10.1111/j.1528-1157.1995.tb02576.x
- The paper
- Suzdak, P. D., & Jansen, J. A. (1995). A Review of the Preclinical Pharmacology of Tiagabine: A Potent and Selective Anticonvulsant GABA Uptake Inhibitor. Epilepsia. https://doi.org/10.1111/j.1528-1157.1995.tb02576.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.